AKTX (Akari Therapeutics Plc) Buxgalteriya kapitallashuvi
Akari Therapeutics (AKTX) kam uchraydigan qon va ko'rish patologiyalariga qarshi dori vositalarini ishlab chiqadi va ushbu grafikdagi narxlar tarixi aktivning dinamikasini namoyish etadi. Ishlab chiqarish sinovlarni tezlashtirish uchun robotlashtirilgan hujayra tahlili tizimlariga tayanadi. Strategiya klinik sikllar doirasidagi birlashmalarga asoslangan bo'lib, joriy ko'rsatkich 0.02 darajasida turibdi, bu esa umumiy makroiqtisodiy tendentsiyalardan mustaqil qolmoqda.
%20-%20Kompaniyaning%20balans%20qiymati&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_AKTX_-_Akari-Therapeutics_-_Company-Book-Value "AKTX Akari Therapeutics PLC Sof aktivlar qiymati (04.07.2022 - 29.10.2026) | 👁️GURU.Markets👁️")
AKTX (Akari Therapeutics Plc): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar
- aksiya narxi va konsensus maqsadli narx:
- biznesning bozor baholash ko'rsatkichlari:
- balans kapitallashuvi ko'rsatkichlari:
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Akari Therapeutics|AKTX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Akari Therapeutics PLC|AKTX - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Akari Therapeutics PLC|AKTX - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Akari Therapeutics|Oraliq qoplash koeffitsiyenti akaritx.com
- foyda va bozor koeffitsiyentlari statistikasi:
Kompaniyaning dastlabki tahlili:Akari Therapeutics
Yuqori sifatli emitentlarni tanlash fundamental koeffitsientlar tahliliga asoslangan bo'lib, bu biznesning real qiymatini bozor kotirovkalariga nisbatan baholash imkonini beradi. Akari Therapeutics (AKTX) uchun kitob kapitalizatsiyasining ushbu darajasi barcha qarzlarni chegirib tashlagandagi umumiy sof aktivlarning kunlik dinamikasini aks ettiradi, bu esa noyob immun patologiyalarini davolash uchun maqsadli komplement tizimi inhibitorlarini ishlab chiqishga resurslar investitsiya qilayotgan sog'liqni saqlash giganti uchun juda muhimdir.
Akari Therapeutics raqobatchilari tahlili
argenx BVBA - Jami sof aktivlar|BNTX (BioNTech SE) - Kompaniyaning sof aktivlari|Buxgalteriya kapitallashuvi ABVX|Kompaniyaning balans qiymati ADMA Biologics, Inc.|Protagonist Therapeutics, Inc. - Sof aktivlar qiymati|Balans kapitallashuvi IMVT|KNSA (Kiniksa Corp) - Kompaniyaning buxgalteriya qiymati|Balans kapitallashuvi GRFS (Grifols, S.A.)|Balans kapitallashuvi adaptivebiotech.com ADPT|CLDX - Kompaniyaning balans qiymati|Kompaniyaning buxgalteriya qiymati AUPH (Aurinia Pharmaceuticals Inc)|BioCryst Pharmaceuticals Inc (BCRX) - Kompaniyaning balans qiymati|Kompaniyaning sof aktivlari Vera Corp|DNTH (Dianthus Therapeutics) - Balans kapitallashuvi|Balans kapitallashuvi pharvaris.com|Kompaniyaning sof aktivlari ABCL (AbCellera Bio)|TRML (Tourmaline Bio Inc) - Kompaniyaning buxgalteriya qiymati|Balans kapitallashuvi PGEN (Intrexon)|Biznesning balans bahosi Pharming Corp (PHAR)|NKTR - Kompaniyaning balans qiymati|upstreambio.com (UPB) - Kompaniyaning sof aktivlari|Zenas Biopharma (ZBIO) - Kompaniyaning balans qiymati|Kompaniyaning sof aktivlari Immunome Inc|Kompaniyaning sof aktivlari GOSS|Balans kapitallashuvi KalVista Corp|Kompaniyaning balans qiymati Septerna Inc (SEPN)|pieris.com - Buxgalteriya kapitallashuvi|Balans kapitallashuvi SVRA (Savara)|Rigel Pharma (RIGL) - Kompaniyaning xususiy kapitali|AnaptysBio Corp - Balans kapitallashuvi|ATXS - Balans kapitallashuvi|enGene Holdings Inc. (ENGN) - Kompaniyaning balans qiymati|rapt.com (RAPT) - Balans kapitallashuvi|JBIO (Aerovate Therapeutics, Inc.) - Balans kapitallashuvi|Balans kapitallashuvi Aclaris Therapeutics Inc.|Kompaniyaning balans qiymati Kyverna (KYTX)|TLSA (Tiziana Life Sciences, Ltd.) - Kompaniyaning buxgalteriya qiymati|Balans kapitallashuvi CABA (Cabaletta Bio, Inc.)|Biznesning balans bahosi ventyxbio.com (VTYX)|THTX: Kompaniyaning sof aktivlari|Kompaniyaning buxgalteriya qiymati AVTX (Avalo Therapeutics, Inc.)|ELDN (Eledon) - Kompaniyaning sof aktivlari|AGEN: Jami sof aktivlar|CLYM (Climb Bio Inc) - Balans kapitallashuvi|ZURA: Kompaniyaning buxgalteriya qiymati|Balans kapitallashuvi ATYR|ADAG - Kompaniyaning xususiy kapitali|Kompaniyaning balans qiymati Ikena Oncology IMA|Kompaniyaning buxgalteriya qiymati STTK|Equillium Bio - Balans kapitallashuvi|CNTB - Balans kapitallashuvi|immunic-therapeutics.com (IMUX) - Kompaniyaning balans qiymati|Sof aktivlar qiymati ATRA (Atara Bio)|IFRX (InflaRx NV) - Balans kapitallashuvi|Kompaniyaning xususiy kapitali X4 Pharmaceuticals, Inc XFOR|Kompaniyaning sof aktivlari ACET (Adicet Bio)|Balans kapitallashuvi celularity.com (CELU)|INmune Bio - Kompaniyaning sof aktivlari|Jami sof aktivlar BRNS (Barinthus Biotherapeutics PLC)|Kezar Life Sciences, Inc - Balans kapitallashuvi|Biznesning balans bahosi SAB Biotherapeutics Inc SABS|ENLV: Balans kapitallashuvi|Kompaniyaning sof aktivlari Q32 Bio|Kompaniyaning balans qiymati GeoVax|Edesa Biotech Inc (EDSA) - Biznesning balans bahosi|Balans kapitallashuvi IBIO|Balans kapitallashuvi carismatx.com (CARM)|Kompaniyaning balans qiymati XTL Biopharmaceuticals XTLB|Balans kapitallashuvi Bolt Biotherapeutics Inc. BOLT|HCWB: Kompaniyaning sof aktivlari|Aptevo Therapeutics - Jami sof aktivlar|AIM (AIM ImmunoTech) - Kompaniyaning sof aktivlari|Buxgalteriya kapitallashuvi ADTX|Kompaniyaning balans qiymati GRI Bio, Inc.|xortx.com - Sof aktivlar qiymati|Balans kapitallashuvi HIND|REVB (Revelation Biosciences Inc) - Kompaniyaning buxgalteriya qiymati|Balans kapitallashuvi INDP (Indaptus)|Balans kapitallashuvi BiondVax Pharmaceuticals SCNI|CALI - Kompaniyaning balans qiymati|Kompaniyaning buxgalteriya qiymati AFMD (Affimed)|allakos.com (ALLK) - Kompaniyaning balans qiymati|Kompaniyaning sof aktivlari HOOKIPA Pharma|IGMS (IGM Biosciences Inc.) - Balans kapitallashuvi|Balans kapitallashuvi iTeos Pharma|Kompaniyaning sof aktivlari OCEA (Ocean Biomedical, Inc.)|TCBP (tcbiopharm.com) - Kompaniyaning buxgalteriya qiymati|Balans kapitallashuvi THRD (Third Harmonic Bio, Inc.)